Monday 13th January 2014
Perfected method of energising the body
Even during my medical studies I was fascinated by the statements made by the “Pope” of sports medicine at the time, Prof. Dr. Herbert Reindell, on the importance of oxygen for health and physical performance and of the possibility of increasing maximum oxygen uptake by means of appropriate physical training and you could say that this set the direction for my professional career: Internal medicine with the emphasis on cardiology, sports medicine, exercise physiology, oxygen metabolism. I was focussed on the role of oxygen as the elixir of life. My meeting and subsequent friendly collaboration with Prof. Manfred von Ardenne, the “inventor” of Oxygen-Multistep-Therapy, also directed me towards my subsequent scientific interests and studies. He was dedicated to developing other, non-sports-related, possibilities for improving the oxygen status of all those who no longer wanted (or were able) to do physical exercise. Like many other therapists before me I was convinced by his argument that an optimum oxygen status is the key to health, well-being and healthy ageing. These contacts led to the writing of many expert reports and studies on oxygen uptake and utilisation and on oxygen therapy, writing of magazine articles, collaborating on articles in books and acting as consultant for associated scientific and patient-oriented organisations.
However, over time I became increasingly sceptical about the traditional external oxygen therapies. For me they were too biased towards increasing the oxygen supply but did not take sufficient account of the simultaneous need to enhance oxygen utilisation and above all to influence oxidative imbalances, which were important reasons that prevented their broad acceptance by science-based medicine.
During this phase a patient told me about the Airnergy company, which claimed that its devices not only facilitate the release of oxygen from haemoglobin into the peripheral tissues via the inhalation of externally activated atmospheric oxygen (singlet oxygen) or the bio photons released during its reversion into its basic state but also improve its utilisation in the mitochondria (associated with ATP production) and also that this would inhibit the excessive production of reactive oxygen species (free radicals).
I was now curious and got in touch with the Managing Director of Airnergy, Mr Guido Bierther, who seemed keen to meet me. As I found out more my interest grew but I also realized that there was still potential and indeed a need for optimisation by means of scientific studies and reports and presentations in the specialist press. The Airnergy company, a “small” (compared to the market-dominating pharmaceutical giants) company with its head office and production facilities in Germany, committed to the area of naturopathy and complementary medicine, made a good impression on me and appeared to be serious and reputable. It had further developed and perfected a previously developed process for producing singlet oxygen, which had produced very good therapeutic results for all possible types of organic diseases and functional disorders that were in some way linked to oxygen deficiency or oxygen radicals, primarily in countries in the Eastern Bloc, South America and Scandinavia. Although there were the first signs of increasing national and international recognition, it was still a long way from conventional science-based medicine with long-term clinical studies on large patient collectives (placebo-controlled, randomised, double-blinded). Opposition arose, not least based on economic concerns, escalating into a university study which showed that spirovitalisation based on the Airnergy principle does not produce any significant beneficial effects. A corresponding analysis of the study quickly showed up defects, for example inadequate questioning, consideration of the parameter VO2 max that is unimportant in the context of spirovitalisation, an excessive time interval between spirovitalisation and data gathering and differences in the composition of the test group and the control group.
In the meantime I had studied the internationally available literature on the therapeutic effectiveness of singlet oxygen and made a scientific evaluation of available patient and therapist reports as well as study results that were available within the company but were largely unpublished.
I was (and continue to be) convinced that spirovital therapy is not only an important extension to the traditional therapeutic options for prevention, clinical treatment and rehabilitation but, over and above this – used independently – makes many beneficial contributions to the maintenance of health, recuperation and overcoming illness and, above all, that – in the sense of an established holistic method – it represents an effective, easy-to-use basic treatment for harmonising the stroma and the hypothalamic – hypophysial – vegetative – hormonal – immunological axis.
The Airnergy principle consists of artificially activating the molecular (inert) oxygen (forming singlet oxygen) but this active state is short-lived and the activated oxygen therefore immediately reverts to its basic state. However, when this happens, energised photons are released and these then disperse ubiquitously via the formation of oxygen bridges in the blood, lymph and interstitial fluid and thereby activate the metabolism of each individual cell in the body.
In spirovital therapy (SVT) the energised photons are diffused via the lungs (inhaled air), in gastrovital therapy (GVT) via the gastrointestinal tract (drinking energised water) and in dermovital therapy (DVT) via the skin (directly). All three forms of therapy developed by Airnergy have their own place but they can also be beneficially combined, thus intensifying the effect. The theory behind them is well founded and in practice they are documented by numerous case reports and increasingly by practical studies. In the meantime the underlying, scientific therapeutic concept has been defined as somatovital therapy and is now well established and has attracted many international awards.
The three main effects of somatovital therapy are:
1. Activation of 2,3-biphosphoglycerate mutase, which results in an increase in 2,3-BPG and therefore a right shift of the oxygen disassociation curve (intensified release of O2 from the Hb in the peripheral tissue).
2. Activation of cytochrome oxidase, which enhances chemiosmosis (reaction of electrons released in the respiratory chain with oxygen to form water) and thereby boosts oxidative phosphorylation (conversion of low-energy ADP into high-energy ATP).
3. Inhibition of NADPH oxidase, which promotes the formation of oxygen radicals temporarily required in metabolism and for defence but which, when present in excess, lead to the development of many organic diseases, subjective ill-health and premature ageing.
Because of the high level of scientific commitment of the company, the Managing Director, his employees, many therapists at home and abroad and many thousands of end users, who are convinced of the benefits of the Airnergy principle because of their daily experiences, beneficial health outcomes, personal discussions and detailed reports, there are now numerous study results, practical observations, patient evaluations, case studies and theoretical explanations on the mode of action and effectiveness of somatovital therapy. These can be obtained from the company’s head office.
It is always moving to share individual stories from case studies and above all to hear how sick people, who have previously tried numerous treatments and consulted many different medical specialists without seeing any significant improvement in their suffering, have managed to find relief, especially in their subjective perception but often – in the long term – in an objective way, by using somatovital therapy, as this example illustrates:
G.S., 67 years of age, suffering for 15 years from pulmonary emphysema and COPD, ongoing treatment from a specialist (most recently Formoterol for bronchial dilation, Budesonid as an anti-inflammatory, also on his own initiative Silicea D6 for clearing mucous). Participates in a lung exercise group, instruction in breathing techniques. Ozone therapy at certain intervals. At resting values of paO2 ≤ 60 mmHg and FEV1 ≤ 30%severe gaseous exchange disturbance, severe hyperinflation and severe peripheral obstructive ventilation disorder. After a few minutes of low intensity loading a further drop in paO2 to 42mmHg, severe loss of performance.
Verbatim report of his own experience with spirovital therapy (Airnergy ®) after 24 days (30 mins twice a day): “…since starting the treatment I have not needed any more ozone therapy…my paO2values are constantly above 70 mmHg, most recently 72 mmHg, even after repeated measurements, my FEV1 value around 40%…one week after starting the treatment I was able to do without Silicea D6 for clearing mucous…due to the daily use of the spirovitalisation device my lungs have cleared in an incredible way…clear mucus is loosening the stubborn green-yellow mucus as it were so that I can expectorate properly and frequently…even when measured at night there was no longer any oxygen deficiency and the values were always in the normal range at approx. 94%…in addition to this, my powers of concentration and my level of well-being have improved significantly, I feel full of energy…when I go walking I no longer need to stop every 20 steps…I no longer feel totally exhausted after taking part in the lung exercises, on the contrary I would like to carry on… I am eager to see what else will happen over the next few weeks…”
In summary somatovital therapy is a universally applicable, convenient method of treatment that is acceptable to users and therapists alike, either on its own or in combination with other methods of treatment. So far, despite many thousands of applications, there are no known significant side-effects or intolerance reactions. Somatovital therapy with its individual options (SVT, GVT, DVT) represents a serious and highly-recommended basic holistic method of healing to supplement conventional science-based medicine.
Univ.-Prof. Dr. med. Klaus Jung